Time-restricted eating reduces CVD risk for older breast cancer survivors
May 19, 2022
Cardiovascular disease risk for breast cancer survivors fell by 15% following an eight-week time-restricted eating intervention.
Flu shots lower risk of cardiac events by 34 percent: study
May 04, 2022
A flu shot can offer significant protection to patients at high risk for adverse cardiovascular events, according to a new analysis.
Subjective cognitive impairment linked to MACE in T2DM
Apr 26, 2022
Among individuals with type 2 diabetes, country-standardized cognitive score may predict risk for cardiovascular events
U.S. lifespan on the rise while cardiovascular issues decline, long-term study finds
Apr 20, 2022
Better healthcare access and preventive measures have contributed to continued improvements in life expectancy and cardiovascular outcomes since the 1960s, investigators say.
Coffee tied to better heart health, no added risk for Afib, studies find
Mar 25, 2022
Drinking two to three cups of coffee daily is linked to a lower risk of heart disease and atrial fibrillation, investigators say. The findings, across two studies, held true for people with and without...
Effect of statins only ‘modest’ in lowering cardiovascular risk, study finds
Mar 16, 2022
Statins are often prescribed as standard-of-care for preventing adverse cardiovascular events in patients with high cholesterol levels. But the results of a new study question the basis for these clinical...
COVID-19 vaccination poses no risk of serious adverse events to elderly, large study finds
Nov 29, 2021
People aged 75 years and older have zero risk of serious adverse cardiovascular events after vaccination with the Pfizer-BioNTech COVID-19 vaccine, a new national study has found.
AHA’s new heart-health dietary advice highlights personal patterns, style
Nov 23, 2021
The emphasis is now on dietary patterns, not specific foods or nutrients, the lead author says. “And it’s not just about what people shouldn’t be eating.”
Stimulants raise elders’ cardiovascular risk by 40 percent: study
Oct 26, 2021
In the first 30 days after starting a new prescription for stimulants, older adults are at high risk for heart attack, stroke and arrhythmia, investigators say.
Low-dose aspirin does not reduce adverse heart, lung outcomes in stable COVID patients: study
Oct 19, 2021
Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...